Risk factors and presentations of periventricular venous infarction vs arterial presumed perinatal ischemic stroke

Archives of Neurology
Adam KirtonGabrielle deVeber

Abstract

To determine whether clinical presentations and risk factor profiles differ between periventricular venous infarction (PVI) and arterial presumed perinatal ischemic stroke (APPIS). Retrospective cohort study. A total of 59 children with presumed perinatal ischemic stroke (PPIS) from the SickKids Children's Stroke Program who were carried to term (63% boys). Single tertiary care center subspecialty program. Participants had validated magnetic resonance imaging classification to define PVI and APPIS subgroups. Clinical presentations, times to parental and physician concern, age at diagnosis, and standardized risk factor evaluations including maternal, fetal, obstetrical, neonatal, and prothrombotic variables. Patients with PVI and APPIS were compared using chi(2) or Fisher exact tests and Wilcoxon rank sum or Mann-Whitney U tests. A total of 12 children (20%) had PVI and 47 (80%) had APPIS. Median parental concern was 5 months, with delays to physician concern (7 months) and diagnosis (12 months). Delays were longer in PVI cases compared with APPIS (P = .002). Most presented with asymmetrical motor development but children with APPIS were more likely to present with seizures or nonmotor delays (P = .01). Children with APPIS were ...Continue Reading

Associated Clinical Trials

Citations

Dec 17, 2014·Lancet Neurology·Adam Kirton, Gabrielle deVeber
Jun 15, 2011·Journal of Child Neurology·Aleksandra Mineyko, Adam Kirton
Oct 3, 2015·Brain & Development·Yukihiro KitaiHiroshi Arai
Aug 21, 2013·Seminars in Pediatric Neurology·Antoinette NguyenJerome Y Yager
Oct 30, 2015·Human Brain Mapping·Mickael DinomaisUNKNOWN AVCnn Study Group
May 2, 2014·Journal of Magnetic Resonance Imaging : JMRI·Jaladhar NeelavalliMoriah E Thomason
Feb 18, 2014·Developmental Medicine and Child Neurology·Anna P Basu
Aug 8, 2015·Clinics in Perinatology·Momoko Yoshimoto, Joyce M Koenig
Jan 8, 2013·Research in Developmental Disabilities·Chao-Ying ChenJill C Heathcock
Jan 13, 2015·Research in Developmental Disabilities·Chao-Ying ChenJill C Heathcock
Feb 28, 2014·Developmental Neuropsychology·Kara MuriasGiuseppe Iaria
Jul 30, 2016·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Adam Kirton
Nov 29, 2011·Magnetic Resonance Imaging Clinics of North America·Roxana S Gunny, Doris Lin
Aug 5, 2015·Journal of Child Neurology·Lara HubermannAnnette Majnemer
Oct 9, 2015·Journal of Child Neurology·Pilvi IlvesTiina Talvik
Feb 13, 2018·Continuum : Lifelong Learning in Neurology·Catherine Amlie-Lefond
Oct 10, 2013·Stroke; a Journal of Cerebral Circulation·Adam Kirton, Gabrielle Deveber
Aug 3, 2017·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Aleksandra MineykoAdam Kirton
Jul 25, 2019·Journal of Child Neurology·Jason P LockrowCatherine Amlie-Lefond
Mar 17, 2020·Journal of Pediatric Ophthalmology and Strabismus·Jeremy J KudrnaNatalie C Kerr
Jul 31, 2020·Neurology·Aleksandra MineykoAdam Kirton
Jan 29, 2019·Stroke; a Journal of Cerebral Circulation·Donna M FerrieroUNKNOWN American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing
Aug 9, 2020·Paediatrics & Child Health·Zachary BoychuckUNKNOWN PROMPT Group
Nov 11, 2019·Neuroradiology·Kshitij MankadWinston Chong
Oct 24, 2020·Developmental Medicine and Child Neurology·Mary J DunbarAdam Kirton
Jan 15, 2019·NeuroImage. Clinical·Brandon T CraigAdam Kirton
Mar 3, 2021·NeoReviews·Ratika Srivastava, Adam Kirton
Mar 19, 2019·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Joel FlussStéphane Chabrier
Jun 16, 2021·Nature Reviews. Neurology·Adam KirtonHelen L Carlson
Aug 11, 2021·Developmental Medicine and Child Neurology·Melissa VitaglianoAdam Kirton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.